EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease

BACKGROUND: Gocovri(®) (amantadine) extended release capsules are approved for the treatment of dyskinesia in patients with Parkinson’s disease (PD) receiving levodopa-based therapy. OBJECTIVE: To evaluate the long-term safety, tolerability, and efficacy of Gocovri in patients with PD experiencing l...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Parkinsons Dis
Main Authors: Tanner, Caroline M., Pahwa, Rajesh, Hauser, Robert A., Oertel, Wolfgang H., Isaacson, Stuart H., Jankovic, Joseph, Johnson, Reed, Chernick, Dustin, Hubble, Jean
Format: Artigo
Sprog:Inglês
Udgivet: IOS Press 2020
Fag:
Research Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7242830/
https://ncbi.nlm.nih.gov/pubmed/31929122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-191841
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker